Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Eveliqure announces the initiation of a Phase 1 clinical study of its combined Shigella and ETEC vaccine candidate

(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity … Read the full press release

The COVID-19 vaccine based on Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant system secures 300 million doses order from the European Commission (EC)

Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system (PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused … Read the full press release

Roche unveils new Anti-SARS-CoV-2 serology test to quantitatively measure antibodies in people exposed to SARS-CoV-2

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. The test  targets antibodies against the spike protein. This is the focus of vaccines in development … Read the full press release

ESMO Virtual Congress 2020: Libtayo positive pivotal data offer hope for the treatment of advanced basal cell carcinoma, a difficult-to-treat cancer

Libtayo is the first investigational medicine to show a clinical benefit in advanced basal cell carcinoma following treatment with a hedgehog inhibitor in a prospective trial 31% objective response rate seen in trial patients, and an estimated 85% of responses … Read the full press release

Dr. Jean-Christophe Rufin to succeed Xavier Darcos as President of Sanofi Espoir Corporate Foundation

(PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced it has appointed Dr. Jean-Christophe Rufin as President of the Sanofi Espoir Corporate Foundation, aimed at reducing inequalities in health … Read the full press release

Sanofi tender offer for Principia Biopharma outstanding shares, August 28 – September 25, 2020

(PRESS RELEASE) PARIS, 28-Aug-2020 — /EuropaWire/ — French multinational pharmaceutical company Sanofi announces its intention to commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of Principia Biopharma Inc. for $100 per share … Read the full press release

Immune-mediated diseases biopharmaceutical Principia Biopharma Inc. acquired by Sanofi for approximately EUR 3.1 billion ($3.68 billion)

Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple sclerosis (MS), making commercialization more efficient and eliminating future royalty payments Allows expansion of SAR442168 development program into other central … Read the full press release

New EU / AstraZeneca deal to help EU member states access the AZD1222 COVID-19 vaccine at no profit during the pandemic

(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the AZD1222 COVID-19 vaccine. Building … Read the full press release

Palette Life Sciences AB and Gedeon Richter Plc. Receive National Marketing Authorization in the United Kingdom for Novel Pain Relief Product, LIDBREE™

(PRESS RELEASE) SANTA BARBARA, CALIF., U.S.A. / BUDAPEST / STOCKHOLM, 5-Aug-2020 — /EuropaWire/ — Palette Life Sciences AB (‘Palette’) with Gedeon Richter Plc. (‘Richter’), today announced that as a part of a decentralised regulatory procedure including thirty European Union Economic … Read the full press release

Palette Life Sciences launches Deflux.com/UK, an online resource for paediatric urologists, parents and caregivers in the United Kingdom

Deflux.com/UK features important information about VUR, including symptoms, causes, risk factors and treatment options, such as Deflux®

Deflux.com/UK provides valuable information regarding vesicoureteral reflux (VUR); connects parents and caregivers of children with VUR with paediatric urologists (PRESS RELEASE)SANTA BARBARA, CALIF., U.S.A. / STOCKHOLM SWEDEN, 4-Aug-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company … Read the full press release

Siemens AG on Varian acquisition by Siemens Healthineers: a transformational step of this kind wouldn’t have been possible in Siemens AG’s old conglomerate structure

Transformational milestone in execution of Siemens’ Vision 2020+ strategy Siemens Healthineers intends to acquire 100 percent stake in U.S. healthcare company at a purchase price of around $16.4 billion Acquisition to create global leader in cancer research and therapeutics and … Read the full press release

DHL Global Forwarding recertified for IATA CEIV Pharma and gets IATA’s approval for its training program

DHL once again been recognized by IATA for offering the highest standards for life sciences and healthcare shipments on a global level Air freight market leader DHL best positioned for more complex transports with its quality assurance initiative IATA also … Read the full press release

Four-year results from EU RCT validate the long-term safety profile of Philips’ Stellarex low-dose Drug-Coated Balloon

(PRESS RELEASE) AMSTERDAM, 26-Jun-2020 — /EuropaWire/ — The global leader in health technology Royal Philips (NYSE: PHG, AEX: PHIA) has announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). New data from the EU RCT reconfirms … Read the full press release

Roche unveils automated digital pathology algorithm to aid non-small cell lung cancer diagnosis

uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances personalised healthcare with development of image analysis algorithms using artificial intelligence Faster, more accurate … Read the full press release

Ireland-based PrecisionBiotics Group now part of Novozymes

(PRESS RELEASE) COPENHAGEN, 25-Jun-2020 — /EuropaWire/ — Biotechnology company Novozymes announces its acquisition of PrecisionBiotics Group Limited. The acquisition will advance Novozymes’ activities in the area of biological solutions for human oral and gut health. PrecisionBiotics Group, based in Cork, … Read the full press release

Co-op Health: Brits aged 55 and over more likely to move offline as retailers open across the UK

Brits aged 55 and over are least likely to continue using online services as often as they have during lockdown Study shows that 70% of UK adults prefer conducting their daily activities in person Despite this, health services such as … Read the full press release

Palette Life Sciences Announces European Distribution Expansion for Deflux® and Solesta® for More Than Twenty Countries Through Five Leading Distributors and Direct Sales Effort

(PRESS RELEASE) STOCKHOLM, SWEDEN / SANTA BARBARA, CALIF., USA, 15-Jun-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced global distribution expansion for two of Palette’s products, Deflux and … Read the full press release

AstraZeneca: two trials show long-term efficacy and tolerability of Calquence (acalabrutinib) in chronic lymphocytic leukaemia

ACE-CL-001 trial showed an overall response rate of 97% with a sustained safety profile for previously untreated patients after more than four years In pivotal ASCEND trial, 82% of patients with relapsed or refractory disease treated with Calquence remained progression … Read the full press release

New data from AstraZeneca’s renal medicines will be presented at the 57th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress

(PRESS RELEASE) CAMBRIDGE, 5-Jun-2020 — /EuropaWire/ — British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca announced it will present new data across continuum of care from its broad renal portfolio during the 57th virtual congress of the European Renal Association – … Read the full press release

Liver cancer: Roche’s Tecentriq in combination with Avastin approved by US FDA

Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or metastatic hepatocellular carcinoma Tecentriq combination improved overall survival and progression-free survival compared to the previous standard of care Application approved … Read the full press release

SGS welcomes Edward R. Zartler, Ph.D as head of its biologics business across the United States

(PRESS RELEASE) GENEVA, 29-May-2020 — /EuropaWire/ — Leading bio/pharmaceutical analytical and bioanalytical contract solutions provider SGS announces the appointment of Edward R. Zartler, Ph.D as Director of Biopharmaceutical Services (USA). Edward, who joined SGS in May 2020, takes responsibility for … Read the full press release

Rare disease: Enhertu of AstraZeneca and Daiichi Sankyo now with Orphan Drug Designation in the US for treatment of gastric cancer

(PRESS RELEASE) CAMBRIDGE, 22-May-2020 — /EuropaWire/ — Enhertu, jointly developed by British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca and the second-largest pharmaceutical company in Japan Daiichi Sankyo (Daiichi Sankyo Company, Limited), has just been granted Orphan Drug Designation (ODD) in … Read the full press release

AstraZeneca expects to begin first deliveries of the University of Oxford’s vaccine in September 2020

The company received support of more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) Broad and equitable supply of the vaccine throughout the world at no profit during the pandemic First agreements for at least 400 … Read the full press release

Fujirebio Europe: Atila Biosystems’ iAMP COVID-19 Detection Kit has just been CE marked

(PRESS RELEASE) GHENT, 12-May-2020 — /EuropaWire/ — Fujirebio Europe, part of Japanese in vitro diagnostics (IVD) testing leader Fujirebio, has just announced the product it distributes across Europe the iAMP® COVID-19 Detection kit from its partner Atila Biosystems, Inc. of … Read the full press release

DSM launches new high-quality DHA oil for maternal and early life nutrition solutions

(PRESS RELEASE) PARSIPPANY, NJ, USA, 11-May-2020 — /EuropaWire/ — Global science-based company active in Nutrition, Health and Sustainable Living, Royal DSM launches new, high-quality life’sDHA® SF55-O200DS oil for maternal and early life nutrition solutions. This ingredient contains a minimum of … Read the full press release

MEDIS medical imaging systems acquires Advanced Medical Imaging Development S.r.l. (AMID) and secures further investment from Van Herk Ventures

MEDIS medical imaging systems acquires Advanced Medical Imaging Development S.r.l. (AMID) and secures further investment from Van Herk Ventures

(PRESS RELEASE) LEIDEN, Netherlands, 11-May-2020 — /EuropaWire/ — MEDIS, a leading developer and supplier of software applications for image-based diagnosis and quantitative assessment of cardiovascular disease, today announced that it acquired Advanced Medical Imaging Development S.r.l. (AMID), a developer and … Read the full press release

University of Zurich researchers announce novel immunotherapy against leukaemia

The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University of Zurich researchers have announced a study that is showing how hematopoietic stem cells from a healthy donor can help … Read the full press release

Kuehne + Nagel’s entire KN PharmaChain air network receives first in the industry IATA CEIV Pharma re-certification

First-in-the-industry full network IATA CEIV re-certification Confirmation of the highest quality and safety of KN PharmaChain (PRESS RELEASE) SCHINDELLEGI, 8-May-2020 — /EuropaWire/ — Global logistics provider Kuehne + Nagel has announced, toghether with IATA, that it has set a benchmark with first-in-the-industry … Read the full press release

ASCO20 Virtual Scientific Program: Roche to present new data from clinical trials of approved and investigational medicines across 21 cancer types

First clinical data from tiragolumab, Roche’s novel anti-TIGIT cancer immunotherapy, in combination with Tecentriq® (atezolizumab) in patients with PD-L1-positive metastatic non-small cell lung cancer (NSCLC) Updated overall survival data for Alecensa® (alectinib), in people living with anaplastic lymphoma kinase (ALK)-positive … Read the full press release

Triton Fund IV company, Bormioli Pharma successfully completes 100% acquisition of GCL Pharma

(PRESS RELEASE) PARMA, Italy, 16-Apr-2020 — /EuropaWire/ — Triton announces that Bormioli Pharma has successfully completed the acquisition of 100% of GCL Pharma. The Italian company based in Vasto (Chieti), previously part of Guala Closures Group, specializes in the production … Read the full press release